Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,459	1,805	1,704	1,220	841.86	466.43
Other Revenue	372.99	372.99	234.23	198.65	112.23	20.82
Revenue	2,832	2,178	1,938	1,419	954.1	487.24
Revenue Growth (YoY)	34.04%	12.37%	36.63%	48.69%	95.81%	-0.83%
Cost of Revenue	2,209	1,638	1,156	870.26	646	289.4
Gross Profit	623.28	539.66	782.37	548.39	308.1	197.85
Selling, General & Admin	261.66	221.48	172.08	142.22	79.93	42.76
Research & Development	140.46	124.05	108.82	78.61	52.84	30.12
Other Operating Expenses	1.22	-13.41	4.55	7.97	6.58	6.32
Operating Expenses	403.13	330.9	285.77	231.29	139.03	79.4
Operating Income	220.15	208.75	496.6	317.1	169.06	118.45
Interest Expense	-51.66	-37.87	-10.64	-0.54	-1.11	-2.83
Interest & Investment Income	16.13	5.25	5.91	10.64	7.5	0.33
Currency Exchange Gain (Loss)	14.04	14.04	7.06	5.43	-0.16	-4.37
Other Non Operating Income (Expenses)	-15.21	-3.3	-2.66	-0.59	-0.39	-0.29
EBT Excluding Unusual Items	183.46	186.87	496.27	332.04	174.91	111.3
Gain (Loss) on Sale of Investments	-1.62	-	-0.31	-0.75	1.06	-
Gain (Loss) on Sale of Assets	-0.35	-0.37	-2.67	-4.62	-0.36	-0.3
Asset Writedown	-7.77	-	-	-	-5.61	-
Other Unusual Items	14.9	14.9	12.98	16.32	20.78	28.94
Pretax Income	188.62	201.41	506.27	342.98	190.79	139.94
Income Tax Expense	12.64	16.85	59.67	23.64	22.55	18.84
Earnings From Continuing Operations	175.99	184.56	446.6	319.34	168.24	121.1
Minority Interest in Earnings	11.26	4.96	2.46	0.69	-	-
Net Income	187.25	189.52	449.06	320.03	168.24	121.1
Net Income to Common	187.25	189.52	449.06	320.03	168.24	121.1
Net Income Growth	-37.38%	-57.80%	40.32%	90.23%	38.92%	-4.18%
Shares Outstanding (Basic)	247	231	229	227	208	170
Shares Outstanding (Diluted)	247	231	229	227	208	170
Shares Change (YoY)	7.25%	0.88%	0.72%	9.33%	22.57%	-0.34%
EPS (Basic)	0.76	0.82	1.96	1.41	0.81	0.71
EPS (Diluted)	0.76	0.82	1.96	1.41	0.81	0.71
EPS Growth	-41.61%	-58.16%	39.31%	73.99%	13.35%	-3.85%
Free Cash Flow	-482.07	-723.72	-967.75	-98.92	-84.93	36.93
Free Cash Flow Per Share	-1.96	-3.13	-4.22	-0.43	-0.41	0.22
Dividend Per Share	0.250	0.250	0.621	0.428	0.262	0.160
Dividend Growth	-59.72%	-59.72%	44.99%	63.33%	63.51%	-
Gross Margin	22.00%	24.78%	40.36%	38.66%	32.29%	40.61%
Operating Margin	7.77%	9.59%	25.62%	22.35%	17.72%	24.31%
Profit Margin	6.61%	8.70%	23.17%	22.56%	17.63%	24.85%
Free Cash Flow Margin	-17.02%	-33.23%	-49.93%	-6.97%	-8.90%	7.58%
EBITDA	388.68	347.41	595.44	376.25	216.56	153.49
EBITDA Margin	13.72%	15.95%	30.72%	26.52%	22.70%	31.50%
D&A For EBITDA	168.52	138.66	98.84	59.15	47.5	35.04
EBIT	220.15	208.75	496.6	317.1	169.06	118.45
EBIT Margin	7.77%	9.59%	25.62%	22.35%	17.72%	24.31%
Effective Tax Rate	6.70%	8.37%	11.79%	6.89%	11.82%	13.46%
Revenue as Reported	2,832	2,178	1,938	1,419	954.1	487.24
Advertising Expenses	-	4.84	3.33	1.33	0.7	0.37

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.